Chroma Medicine

Vic Myer, Ph.D., Chief Scientific Officer

Oct. 10 | 4:45pm | Rentschler ATMP Ballroom 

Boston, MA


Chroma Medicine is a biotechnology company pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, to deliver precise, programable single-dose therapeutics while preserving genomic integrity. The company was founded by the world’s foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development.

By using this website you agree to accept our Privacy Policy and Terms & Conditions